K31.A2
Gastric intestinal metaplasia with dysplasia
Clinical Classification Guidelines
Medical Intelligence & Overview
Gastric intestinal metaplasia with dysplasia is a medical condition characterized by abnormal changes in the lining of the stomach. This condition involves the transformation of the stomach's normal epithelial cells into intestinal-like cells, which can sometimes become precancerous. Recognized under the ICD-10 code K31.A2, this diagnosis warrants careful monitoring due to its potential to develop into gastric cancer if left unmanaged. Understanding its causes, symptoms, diagnostic methods, and treatment options can help patients and healthcare providers manage the condition effectively.
Causes & Symptoms
Clinical Causes: Chronic Helicobacter pylori infection Prolonged gastritis or inflammation of the stomach lining Long-term use of certain medications like proton pump inhibitors Lifestyle factors such as smoking, excessive alcohol consumption, and poor diet Genetic predisposition and family history of gastric cancer Environmental factors, including exposure to carcinogens
Key Symptoms: Indigestion or dyspepsia Persistent stomach pain or discomfort Nausea and vomiting Unexplained weight loss Loss of appetite Anemia-related symptoms like fatigue and pallor Gastrointestinal bleeding, which may manifest as black stool or vomiting blood
Diagnostic & Treatment
Diagnosis Path: Upper gastrointestinal endoscopy to visually inspect the stomach lining and obtain tissue samples Biopsy of suspicious areas during endoscopy for microscopic analysis Histopathological examination to identify intestinal metaplasia and dysplastic changes Additional testing such as PCR or special staining techniques to detect Helicobacter pylori infection Imaging studies like CT scans may be used in advanced cases to evaluate for potential progression or complications
Treatment Protocols: Eradication of Helicobacter pylori infection using specific antibiotics and acid-suppressing medications Regular surveillance with periodic endoscopy and biopsies to monitor for progression or development of cancer Lifestyle modifications, including quitting smoking, limiting alcohol intake, and adopting a healthy diet rich in fruits and vegetables Pharmacological therapy to manage inflammatory symptoms and minimize further damage In some cases, surgical intervention may be considered if dysplasia progresses or if early gastric cancer is detected
Clinical Advice & FAQs
Billing Guidance
Is K31.A2 a billable ICD-10 code?
Yes, K31.A2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K31.A2?
Clinical documentation must specify the nature of Gastric intestinal metaplasia with dysplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference